On November 10, 2020, the U.S. Food and Drug Administration (FDA) issued draft guidance to encourage food manufacturers to clearly declare sesame in the Ingredient Statement. This voluntary measure reflects a need for such information by consumers who are allergic or sensitive to sesame.
While sesame can cause allergic reactions, it is not one of the eight major food allergens mandated by the 2004 Food Allergen Labeling and Consumer Protection Act (FALCPA) to be called out on food labels. Since sesame may be listed or included as “spice” or “flavoring”, consumers could be unaware of its presence in a food product when reviewing the Ingredient Statement. FDA is also recommending that if an ingredient contains sesame, such as tahini, then sesame should be included in parentheses next to the item in the Ingredient Statement.
Comments are being considered prior to final guidance by FDA. For consumers who have sesame allergies or sensitivities, this new requirement will be helpful when selecting food items.
Contact Nett Nutrition today to learn how we can support your company’s nutrition labeling efforts to comply with the new FDA guidelines. 516.921.1514 or info@nettnutrition.com
